The epidemiology of prostate cancer: Clues for chemoprevention

Research output: Contribution to journalArticle

Abstract

Prostate cancer exists as two different clinical entities; a 'latent' or 'histologic' form and a clinically evident form. While the prevalence of histologic prostate cancer is similar around the world, the prevalence of clinical cancer varies dramatically from country to country. This suggests that promotional events which contribute in the transformation of histologic cancer to clinically important cancer vary from country to country and population to population. The ultimate goal of epidemiologic studies is to identify risk factors, i.e., promotional agents, for prostate cancer and to use this knowledge for disease prevention strategies.

Original languageEnglish (US)
Pages (from-to)419-422
Number of pages4
JournalIn Vivo
Volume8
Issue number3
StatePublished - 1994

Keywords

  • chemoprevention
  • epidemiology
  • prostate cancer

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology

Fingerprint Dive into the research topics of 'The epidemiology of prostate cancer: Clues for chemoprevention'. Together they form a unique fingerprint.

  • Cite this